11.96
-0.24 (-1.97%)
-0.24 (-1.97%)
Upgrade to Real-Time
Afterhours (Closed)
Low
9.63
High
18.13
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Neoleukin Therapeutics Inc | NLTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.24 | -1.97% | 11.96 | 00:00:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.31 | 11.77 | 12.345 | 11.96 | 12.20 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 11.20 | 15.00 | 3.80 | 1 | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,782 | 121,326 | $ 12.03 | $ 1,459,983 | 392,495 | 9.63 - 18.13 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:03:06 | formt | 985 | $ 11.96 | USD |
Neoleukin Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 501.54M | 41.93M | 35.82M | $ - | $ - | -2.41 | -27.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Neoleukin Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NLTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.01 | 12.70 | 11.68 | 12.14 | 149,174 | -0.05 | -0.42% |
| 1 Month | 11.33 | 13.30 | 11.05 | 12.01 | 249,690 | 0.63 | 5.56% |
| 3 Months | 12.90 | 14.90 | 10.81 | 12.44 | 214,647 | -0.94 | -7.29% |
| 6 Months | 12.18 | 17.95 | 10.07 | 13.00 | 307,154 | -0.22 | -1.81% |
| 1 Year | 12.53 | 18.13 | 9.63 | 13.18 | 319,573 | -0.57 | -4.55% |
| 3 Years | 3.98 | 18.13 | 2.53 | 11.40 | 328,270 | 7.98 | 200.5% |
| 5 Years | 3.98 | 18.13 | 2.53 | 11.40 | 328,270 | 7.98 | 200.5% |
Neoleukin Therapeutics Description
| Neoleukin Therapeutics Inc operates as a biopharmaceutical company. It generates immunotherapies using de novo protein design technology. The firm uses computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. Its product line comprises of NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. |
